Zyamis (Midazolam)

midazolam 2.5 mg/0.25 mL oral liquid, 0.25 mL syringe · BUCCAL · PBS code 15381M

AUTHORITY_REQUIRED

What it costs

AU$120 PBS-determined price per 2 units

Most patients pay only the standard PBS co-payment, not the full price above — up to AU$25.00 per script (general) or AU$7.70 (concession/Safety Net) in 2026. The figure above is what the PBS pays the pharmacy; the Australian Government subsidises the rest. Always confirm the current amount with your pharmacist.

• First listed on the PBS: 2026-07-01.
• Repeats: 1.
• PBS program: GE.

Eligibility criteria for subsidised access

The following is the government's own wording from the PBS Schedule, shown unchanged.

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Generalized convulsive status epilepticus

Continuing treatment

Patient must have previously received PBS-subsidised treatment with this drug for this condition.

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 2

At the time of the authority application, practitioners should request the appropriate quantity to cater for the patient's circumstances.

Up to a maximum of 10 syringes for each prescription can be authorised for patients with high frequency seizures.

Sponsor: Clinect Pty Ltd ABN 76 150 558 473

Not medical advice. Voxsanity republishes public PBS data in plain English. PBS listing status and criteria can change; always confirm current subsidised availability with your doctor or pharmacist.

Source: Pharmaceutical Benefits Scheme (PBS), © Commonwealth of Australia. Data used and redistributed under permission; not modified from its original wording where displayed verbatim.